Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma

Response criteria for phase II studies of supratentorial malignant glioma.

David R. Macdonald, T L Cascino, S. Clifford Schold et al. · Journal of Clinical Oncology · 1990 · 2.4K citations

Medicine, Oncology, Radiology +17

Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315

Diana F. Nelson, Karen Martz, Hugh Bonner et al. · International Journal of Radiation Oncology*Biology*Physics · 1992 · 635 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07

Tracy T. Batchelor, Kathryn A. Carson, A. O’Neill et al. · Journal of Clinical Oncology · 2003 · 542 citations

Medicine, Oncology, Chemotherapy +13

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma

Carole Soussain, Florence Suzan, Khê Hoang‐Xuan et al. · Journal of Clinical Oncology · 2001 · 337 citations

Medicine, Hematology, Oncology +15

Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS Lymphoma

Paul L. Nguyen, Arnab Chakravarti, Dianne M. Finkelstein et al. · Journal of Clinical Oncology · 2005 · 241 citations · Full text

Medicine, Radiation Oncology, Central Nervous System Radiation Oncology +11